We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

HeartWare International Acquires Valtech Cardio

By HospiMedica International staff writers
Posted on 03 Sep 2015
Print article
Image: The Cardioband direct annuloplasty system (Photo courtesy of Valtech Cardio).
Image: The Cardioband direct annuloplasty system (Photo courtesy of Valtech Cardio).
Medical device developer HeartWare International (Framingham, MA, USA) has bought medical startup Valtech Cardio (Or Yehuda, Israel), developer of a novel heart valve repair and replacement technology, for an estimated USD 920 million in stock.

HeartWare International is a leading innovator of miniaturized circulatory support technologies, such as ventricular assist devices (VADs), which are revolutionizing the treatment of advanced heart failure (HF). The acquisition of Valtech Cardio, which specializes in surgical and transcatheter valve repair and replacement devices for the treatment of mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR), will provide HeartWare with multiple commercial opportunities in the significantly underserved areas of mitral and tricuspid valve diseases, from which many VAD patients suffer.

HeartWare will benefit from a wide technology portfolio, including Cardioband, an interventional, transfemoral, direct annuloplasty system designed for MR and TR repair; CardioValve, a transseptally delivered, low-profile, transcatheter mitral valve replacement (TMVR) system with five degrees of steering maneuverability; Cardinal, a semi-rigid, adjustable, annuloplasty ring system that enables fine-tuning of the ring diameter and leaflet coaptation on a beating heart; and V-Chordal, a surgical and interventional chord replacement system for noninvasive MR repair.

“Valtech provides HeartWare with commercial-stage products for mitral repair, as well as a robust technology pipeline, an advanced R&D center and an impressive, experienced team with a proven track record,” said Doug Godshall, CEO of HeartWare International. “This combination represents an attractive opportunity for value creation for HeartWare shareholders, customers, employees, and patients by expanding HeartWare's footprint in the high-growth structural heart market.”

“By joining HeartWare, we can more quickly and fully realize the potential of our pipeline technologies and further influence the underpenetrated markets that we serve,” said Amir Gross, Founder and CEO of Valtech. “Together, we can offer clinical heart failure teams a compelling portfolio of surgical and interventional technologies to serve the advanced heart failure population.”


Related Links:

HeartWare International
Valtech Cardio


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mechanical Baby Scale
seca 725

Print article

Channels

Surgical Techniques

view channel
Image: The ProScan AI assisted reading tool is designed to unlock the future of gastroenterology (Photo courtesy of AnX Robotica)

AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions

A revolutionary artificial intelligence (AI) technology that has proven faster and more accurate in diagnosing small bowel bleeding could transform gastrointestinal medicine. AnX Robotica (Plano, TX,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more